Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales
Financial Highlights Direct MagnetOs sales rose by 155% to CHF 13.9 million in Q1 2024 from CHF 5.4 million in Q1 2023…
Financial Highlights Direct MagnetOs sales rose by 155% to CHF 13.9 million in Q1 2024 from CHF 5.4 million in Q1 2023…
European Circular Bioeconomy Fund (ECBF), Qbic III and Flanders Future Tech Fund (FFTF) have joined forces to provide a…
Kuros Biosciences (SIX:KURN), a leader in next generation bone graft technologies, held its Annual General Meeting today…
Key Engineering Contracts Awarded and Work is Underway - Steel plant design led by SMS group - Key portions of nickel pl…
ECBF expands its agricultural technology portfolio and invests in Weenat, the European leader in sensors used in agricul…
The Sibanye-Stillwater (Tickers JSE: SSW and NYSE: SBSW) - https://www.commodity-tv.com/... - Board is pleased to annou…
quantumrock, the pioneering force in the financial industry known for its innovative investment solutions, is delighted…
ProteinQure, the leading startup in the computational design of peptide drugs, announces a significant breakthrough in t…
To further fortify its foothold in the Middle East and Africa (MEA) region, quantumrock is proud to announce the expansi…
Financial highlights Direct MagnetOs sales grew by 163% to CHF 31.7 million in 2023, climbing from CHF 12.1 million…